Latest Undisclosed Funding Rounds
Funding announcements whose series or stage was not named. Round amounts and investor roles are shown where disclosed.
- Rounds
- 2,305 All time
- Disclosed funding
- $375.2B 1239 disclosed amounts
- Median round
- $8.9M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| H3 HawkEye 360Company profile Detects, geolocates, and characterizes RF signals using a commercial satellite constellation Detects, geolocates, and characterizes RF signals using a commercial satellite constellation | ≤$125M | Revolving credit facilityUndisclosed | Space tech | United States | Investors | |
| FB Forlong BiotechnologyCompany profile Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer | $17.5M | Pre-Series BUndisclosed | Biotech | China | Investors | |
| EI Eris InnovationsCompany profile IP licensing company developing exchange-traded futures and options products based on the Eris Methodology IP licensing company developing exchange-traded futures and options products based on the Eris Methodology | Undisclosed | StrategicUndisclosed | Fintech | United States | Investors | |
| CA Crux AICompany profile Dedicated AI computing infrastructure combining data centers, networking and Google TPUs as a managed service. Dedicated AI computing infrastructure combining data centers, networking and Google TPUs as a managed service. | $5B | Equity commitmentUndisclosed | AI | United States | Investors | |
| VI Vortex ImagingCompany profile Develops a compact computational ultrasound system for standardized 3D volumetric imaging at the point of care Develops a compact computational ultrasound system for standardized 3D volumetric imaging at the point of care | $12M | Undisclosed | Healthtech | United States | Investors | |
SearchableCompany profile Searchable helps brands measure their presence in AI search and act on content and technical opportunities to improve discovery. Searchable helps brands measure their presence in AI search and act on content and technical opportunities to improve discovery. | $14M | Undisclosed | Enterprise software | United Kingdom | Investors | |
| B BlinkCompany profile Mobile-first employee experience platform connecting frontline workforces across hospitality, retail, and logistics Mobile-first employee experience platform connecting frontline workforces across hospitality, retail, and logistics | $17M | Undisclosed | Enterprise software | United States | Investors | |
MucoLife TherapeuticsCompany profile Developing inhaled peptide medicines to clear mucus obstructions in lung disease. Developing inhaled peptide medicines to clear mucus obstructions in lung disease. | SEK 200K | Medtech4Health nebulization planning grantUndisclosed | Biotech | Sweden | Investors | |
| FT Full-Life TechnologiesCompany profile Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing | $150M | Series D+DebtUndisclosed | Biotech | China | Investors | |
| G GreenpixieCompany profile Provides sustainability intelligence to decarbonise cloud and AI infrastructure usage Provides sustainability intelligence to decarbonise cloud and AI infrastructure usage | £4.7M | Pre-Series AUndisclosed | Climate tech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Innovate UK
Emerald, Go Eve, Nearhuman
39rounds0led - 2NVIDIA
Noeri, Applied Compute, Riverlane
32rounds1led - 3Bethnal Green Ventures
Excelas, HeyLina, Amytis
25rounds0led - 4Future of Health Grant
Healium, NeuroTreasure Solutions, Entrelacs
20rounds0led - 5Peak XV Partners
PowerUp Money, Hex, Meragi
19rounds3led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.